
Ciara Kelly, MBBCh BAO
Medical Oncologist
Titles
Assistant Attending Physician
Clinical Expertise
Bone and Soft Tissue Sarcomas; Merkel Cell Carcinoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Kelly accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-888-4312 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MBBCh BAO, University College Dublin
Residencies
Internal medicine – The Royal College of Physicians of Ireland
Fellowships
Medical Oncology – The Royal College of Physicians Ireland; Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine (Ireland); Medical Oncology (Ireland & Europe)
I am a medical oncologist who has expertise in treating and researching bone and soft tissue sarcomas and merkel cell carcinoma. I work very closely with our team of medical oncologists, surgeons, radiation oncologists, nurses, and patient support advocates. We provide our patients with the best care and treatment options for their unique disease and circumstances.
My research aims to develop new and more personalized therapies to treat sarcomas. I am actively involved in developing and designing clinical trials that will look at novel agents that target molecular changes within tumors. I am also studying innovative combination immunotherapy options that will harness a person’s own immune defenses to fight their cancer. I have a particular interest in advancing our understanding of gastrointestinal stromal tumors and other sarcomas at the molecular level. I am using liquid biopsies to analyze tumor DNA in the blood and tumor biopsies to uncover a biomarker that will ultimately help us match the best treatment option with each individual person’s tumor. When someone is diagnosed with a rare cancer like a sarcoma, they may think there are limited treatment options. At MSK, the rare is not uncommon. We have an entire team of experts who are solely focused on diagnosing and treating sarcomas. We are constantly looking for newer and better ways to care for our patients.
Awards and Honors
- Irish Society of Medical Oncology Scholarship Award (2014)
- American Society of Clinical Oncology (ASCO) Merit Award (2017)
- ASCO Young Investigator Award (2017)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Kelly
- A Phase II Study of AG-120 for Patients with IDH1-Mutant Chondrosarcoma
- A Phase II Study of INBRX-109 for Inoperable or Metastatic Chondrosarcoma
- A Phase II Study of KRT-232 in Merkel Cell Carcinoma That Has Not Responded to Immunotherapy
- A Phase III Study of Avelumab Immunotherapy versus Placebo in Patients with Merkel Cell Carcinoma that Spread to the Lymph Nodes
Read more
- Clinical Trials Co-Investigated by Dr. Kelly
- A Phase I Study of LY3410738 in Patients with Advanced Solid Tumors with IDH1 Mutations
- A Phase I Study of NB003 in People with Gastrointestinal Stromal Tumor or Another Solid Tumor
- A Phase II Study of ASTX727 in People with Malignant Peripheral Nerve Sheath Tumors
- A Phase II Study of Radiation Therapy with or without Avelumab in People with Advanced Merkel Cell Carcinoma
- A Phase III Study of Sunitinib with or without CGT9486 in People with Inoperable or Metastatic Gastrointestinal Stromal Tumors

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Kelly’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ciara Kelly discloses the following relationships and financial interests:
-
ChemoCentryx, Inc.
Provision of Services (uncompensated) -
Exicure, Inc.
Provision of Services (uncompensated) -
Immunicum AB
Provision of Services (uncompensated)
-
Kartos Therapeutics, Inc.
Provision of Services (uncompensated) -
i3 Health
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].